Cancer cells are relentless in their quest to grow and divide, often rewiring their metabolism and modifying RNA to stay one ...

As lung cancer treatments evolve and more data are published, there is a need for updated recommendations on how to manage ...

Lung infections and lung cancer share symptoms like cough and breathlessness, but differ significantly. Infections arise ...

A cutting-edge bronchoscope that is guided with the help of a robot can reach very small tumors growing in hard-to-reach ...

Dr. Jacob A. Sands shares how patients with lung cancer can interpret clinical trial results and how these findings translate to treatment decisions.

Since the development of crizotinib (Xalkori), oncologists can now choose from an array of later-generation drugs in the ...

FLORHAM PARK, N.J. and LONDON and CHARLOTTESVILLE, Va., Sept (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (“Cellectar”) ...

Doctors are experimenting with using lower doses of blockbuster cancer drugs. It could help hundreds of thousands of lives — ...

Many of those women will have dense breasts. Research shows women with extremely dense breast tissue are up to six times more likely to develop cancer than those with fattier breasts. That increased ...

Dr. Singhi speaks with us about the importance of biomarker testing and what you need to know to get the best lung cancer ...

When you're facing metastatic breast cancer, the questions can pile up fast. Here are some clear answers to guide you.

Kelly Paulson, MD, PhD: ES-SCLC is, of course, a very aggressive form of lung cancer that affects about 35,000 Americans each. Most SCLC presents in the metastatic setting or extensive stage, and ...